detreman - Zoekresultaten

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eleonor 20 0,1 mg - 0,02 mg omh. tabl.

sandoz sa-nv - ethinylestradiol 0,02 mg; levonorgestrel 0,1 mg - omhulde tablet - 0,1 mg - 0,02 mg - ethinylestradiol 0.02 mg; levonorgestrel 0.1 mg - levonorgestrel and ethinylestradiol

Europese Unie - Nederlands - EMA (European Medicines Agency)

sarclisa

sanofi winthrop industrie - isatuximab - multiple myeloma - antineoplastische middelen - sarclisa is indicated: in combination with pomalidomide and dexamethasone, for the treatment of adult patients with relapsed and refractory multiple myeloma (mm) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor (pi) and have demonstrated disease progression on the last therapy. in combination with carfilzomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therapy (see section 5.